MedPage Today) — Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma (HCC), but real-world outcomes remain heavily constrained by liver function and comorbidity burden…
Liver Cancer Treatment Landscape Shifts Rapidly, but Best Sequencing Still Unclear

Leave a Comment Leave a Comment
